Macquarie Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Hold |
122,100
| – | – | ﹤0.01% | 1235 |
|
|
2025
Q1 | $2.09M | Hold |
122,100
| – | – | ﹤0.01% | 1210 |
|
|
2024
Q4 | $3.02M | Sell |
122,100
-63,884
| -34% | -$1.58M | ﹤0.01% | 1070 |
|
|
2024
Q3 | $5.3M | Buy |
185,984
+63,884
| +52% | +$1.82M | 0.01% | 951 |
|
|
2024
Q2 | $3.22M | Buy |
122,100
+19,000
| +18% | +$502K | ﹤0.01% | 1087 |
|
|
2024
Q1 | $3.33M | Buy |
103,100
+62,474
| +154% | +$2.02M | ﹤0.01% | 1079 |
|
|
2023
Q4 | $1.71M | Buy |
+40,626
| New | +$1.71M | ﹤0.01% | 1268 |
|
|
2022
Q4 | – | Sell |
-243
| Closed | -$7K | – | 2049 |
|
|
2022
Q3 | $7K | Sell |
243
-977
| -80% | -$28.1K | ﹤0.01% | 2399 |
|
|
2022
Q2 | $5K | Hold |
1,220
| – | – | ﹤0.01% | 2526 |
|
|
2022
Q1 | $7 | Hold |
1,220
| – | – | ﹤0.01% | 2548 |
|
|
2021
Q4 | $10K | Sell |
1,220
-2,803
| -70% | -$23K | ﹤0.01% | 2511 |
|
|
2021
Q3 | $35K | Sell |
4,023
-50,351
| -93% | -$438K | ﹤0.01% | 2325 |
|
|
2021
Q2 | $575K | Buy |
54,374
+3,334
| +7% | +$35.3K | ﹤0.01% | 1679 |
|
|
2021
Q1 | $819K | Buy |
51,040
+29,980
| +142% | +$481K | ﹤0.01% | 1440 |
|
|
2020
Q4 | $973K | Sell |
21,060
-1,598
| -7% | -$73.8K | ﹤0.01% | 1316 |
|
|
2020
Q3 | $798K | Buy |
22,658
+21,757
| +2,415% | +$766K | ﹤0.01% | 1293 |
|
|
2020
Q2 | $22K | Sell |
901
-2,307
| -72% | -$56.3K | ﹤0.01% | 2140 |
|
|
2020
Q1 | $50K | Buy |
+3,208
| New | +$50K | ﹤0.01% | 1811 |
|